PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
3.30%
Revenue growth below 50% of CRK's 14.43%. Michael Burry would check for competitive disadvantage risks.
22.46%
Cost increase while CRK reduces costs. John Neff would investigate competitive disadvantage.
-17.94%
Gross profit decline while CRK shows 19.54% growth. Joel Greenblatt would examine competitive position.
-20.56%
Margin decline while CRK shows 4.47% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.32%
Other expenses growth above 1.5x CRK's 3.70%. Michael Burry would check for concerning trends.
11.03%
Similar operating expenses growth to CRK's 13.75%. Walter Schloss would investigate norms.
19.27%
Total costs growth above 1.5x CRK's 7.94%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
9.05%
D&A growth above 1.5x CRK's 3.71%. Michael Burry would check for excessive investment.
-20.43%
EBITDA decline while CRK shows 13.43% growth. Joel Greenblatt would examine position.
-31.87%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-40.26%
Operating income decline while CRK shows 28.13% growth. Joel Greenblatt would examine position.
-42.17%
Operating margin decline while CRK shows 11.97% growth. Joel Greenblatt would examine position.
154.55%
Other expenses growth while CRK reduces costs. John Neff would investigate differences.
-27.82%
Pre-tax income decline while CRK shows 33.75% growth. Joel Greenblatt would examine position.
-30.13%
Pre-tax margin decline while CRK shows 16.88% growth. Joel Greenblatt would examine position.
-106.94%
Tax expense reduction while CRK shows 35.48% growth. Joel Greenblatt would examine advantage.
15.45%
Net income growth below 50% of CRK's 32.08%. Michael Burry would check for structural issues.
11.76%
Similar net margin growth to CRK's 15.42%. Walter Schloss would investigate industry trends.
16.59%
EPS growth 50-75% of CRK's 29.47%. Martin Whitman would scrutinize operations.
16.59%
Diluted EPS growth 50-75% of CRK's 32.97%. Martin Whitman would scrutinize operations.
No Data
No Data available this quarter, please select a different quarter.
-0.73%
Both companies reducing diluted shares. Martin Whitman would check patterns.